The statistically significant responder analysis results for Mytesi® (crofelemer) in the OnTarget study's prespecified subgroup of ...

Filly, a jaguar from Belize who arrived here earlier this year, has "successfully transferred" to her habitat in the ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel ...

Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is ...